Cynthia Robbins-Roth will redux the orthodoxy of this year's JPMorgan (formerly "H&Q") conference. Join us on January 24th as Dr Robbins-Roth uncovers the obvious, points out the pitfalls of biotech investing, and tells us why Pfizer just might show Genentech how to reconfigure in this, our third epoch of biopharma development.
